Literature DB >> 9638312

Comparative autoradiographic investigations on the tissue distribution of benfotiamine versus thiamine in mice.

R Hilbig1, H Rahmann.   

Abstract

The tissue distribution of two therapeutically applied preparations of B-vitamins were investigated in blood and selected organs (liver, brain, muscle, kidney) of laboratory mice using autoradiographic techniques. Incorporation of lipid-soluble 3H-benfotiamine (CAS 22457-89-2) and water-soluble 3H-thiaminehydrochloride (CAS 67-03-8) (200 microCi, equivalent to 105 mg vitamin/kg body weight) was monitored between 0.75 and 168 h after an oral or subcutaneous administration. The labelled tissue slices were autoradiographically analysed after a differential histochemical extraction procedure to evaluate the respective total radioactivity, the uptake into lipid-soluble, water-soluble and residual macromolecular compounds. Evaluation of these autoradiographic data (given as mumol vitamin preparation/mg tissue equivalent) proved that benfotiamine is incorporated much better than thiaminehydrochloride independent of the administration mode. In muscle and brain tissue a 5 to 25 fold higher amount of tracer incorporation was registered following benfotiamine as compared with the thiamine application, whereas in all other organs the difference in the label was mostly between 10 and 40%. Concerning the organ specific distribution, liver and kidney were the structures labelled highest by both substances and administration procedures. In the liver, concerning all incorporation times, a higher proportion of residual macromolecular compounds was found, whereas in the kidney the proportions of lipid- as well as of water-soluble materials prevailed. These data should be clinically relevant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9638312

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  Benfotiamine increases glucose oxidation and downregulates NADPH oxidase 4 expression in cultured human myotubes exposed to both normal and high glucose concentrations.

Authors:  D A Fraser; N P Hessvik; N Nikolić; V Aas; K F Hanssen; S K Bøhn; G H Thoresen; A C Rustan
Journal:  Genes Nutr       Date:  2011-10-09       Impact factor: 5.523

2.  High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

Authors:  R Babaei-Jadidi; N Karachalias; C Kupich; N Ahmed; P J Thornalley
Journal:  Diabetologia       Date:  2004-12-11       Impact factor: 10.122

3.  Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.

Authors:  Marie-Laure Volvert; Sandrine Seyen; Marie Piette; Brigitte Evrard; Marjorie Gangolf; Jean-Christophe Plumier; Lucien Bettendorff
Journal:  BMC Pharmacol       Date:  2008-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.